Works matching IS 0008543X AND DT 2007 AND VI 109 AND IP 6

Results: 31

Patients with differentiated thyroid cancer have a venous gradient in thyroglobulin levelsPresented in part at the 77th Annual Meeting of the American Thyroid Association, Phoenix, Arizona, October 11–15, 2006.

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1078, doi. 10.1002/cncr.22505

By:

Electron Kebebew;
Emily Reiff

Publication type:

Article

A comparison of low‐dose cytarabine and hydroxyurea with or without all‐trans retinoic acid for acute myeloid leukemia and high‐risk myelodysplastic syndrome in patients not considered fit for intensive treatmentSee related Editorial on pages 000–000, this issue.The following investigators entered patients in this trial: Aberdeen Royal Infirmary: Dr. D. J. Culligan and Dr. J. Tighe; Altnagelvin Area Hospital: Dr. M. F. Ryan; Arrowe Park Hospital: Dr. D. W. Galvani; Barnet General Hospital: Dr. A. Virchis; Belfast City Hospital: Dr. R. J. G. Cuthbert, Dr. M. F. McMullin, and Dr. T. C. M. Morris; Bradford Royal Infirmary: Dr. L. A. Parapia and Dr. A. T. Williams; Bristol Royal Infirmary: Dr. G. L. Scott and Dr. G. R. Standen; Broadgreen Hospital: Dr. P. Chu; Canterbury Health Laboratories: Dr. W. N. Patton; Central Middlesex Hospital: Dr. K. Ryan; Christchurch Hospital: Dr. R. L. Spearing; Christie Hospital: Dr. R. Chopra; City Hospital National Health Service (NHS) Trust: Dr. D. Barefor

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1114

By:

Alan K. Burnett;
Donald Milligan;
Archie G. Prentice;
Anthony H. Goldstone;
Mary F. McMullin;
Robert K. Hills;
Keith Wheatley

Publication type:

Article

Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle‐aged men.

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1192, doi. 10.1002/cncr.22534

By:

Zhihong Gong;
Ilir Agalliu;
Daniel W. Lin;
Janet L. Stanford;
Alan R. Kristal

Publication type:

Article

A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment.

Published in:

2007

By:

Burnett, Alan K;
Milligan, Donald;
Prentice, Archie G;
Goldstone, Anthony H;
McMullin, Mary F;
Hills, Robert K;
Wheatley, Keith

Publication type:

journal article

Overexpressed Raf‐1 and phosphorylated cyclic adenosine 3′‐5′‐monophosphatate response element‐binding protein are early markers for lung adenocarcinoma.

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1164, doi. 10.1002/cncr.22520

By:

Maria Cekanova;
Mourad Majidy;
Thomas Masi;
Hussein A. N. Al‐Wadei;
Hildegard M. Schuller

Publication type:

Article

Survivin expression is associated with bladder cancer presence, stage, progression, and mortality.

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1106, doi. 10.1002/cncr.22521

By:

Shahrokh F. Shariat;
Raheela Ashfaq;
Pierre I. Karakiewicz;
Osamah Saeedi;
Arthur I. Sagalowsky;
Yair Lotan

Publication type:

Article

Multidisciplinary frontiers in breast cancer management: A surgeon's perspective.

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1019, doi. 10.1002/cncr.22519

By:

S. Eva Singletary

Publication type:

Article

Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F‐FDG PET/CT in a tuberculosis‐endemic countryPresented at the 2006 Radiological Society of North America (RSNA) scientific assembly (#SST18‐09), November 26–December 1, 2006. Chicago, Illinois.: Diagnostic efficacy in 674 patients

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1068, doi. 10.1002/cncr.22518

By:

Yoon Kyung Kim;
Kyung Soo Lee;
Byung‐Tae Kim;
Joon Young Choi;
Hojoong Kim;
O Jung Kwon;
Young Mog Shim;
Chin A Yi;
Ha Young Kim;
Myung Jin Chung

Publication type:

Article

Switching to an aromatase inhibitor provides mortality benefit in early breast carcinomaPresented in part as a poster at the Breast Cancer Poster Discussion Session I. 42nd ASCO Annual Meeting, Atlanta, Georgia, June 2–6, 2006.The following centers and investigators were involved in the GROCTA 4B and ITA trials: Ospedale D. Lazzaro, Alba (G. Porcile); Ospedale San Donato, Arezzo (M. Rinaldini, S. Scali); Azienda Ospedaliera di Bologna‐Policlinico S. Orsola Malpighi, Bologna (G. Paladini, A. Fini); Policlinico Universitario Monserrato, Cagliari (B. Massidda, M.T. Ionta); Istituto Oncologico S. Luigi‐S. Currò, Catania (N. Restuccia, R. Bordonaro, D. Giuffrida); Presidio Ospedaliero, Casalpusterlengo (R. Franchi, G. Tansini); Università degli Studi “G. D'Annunzio”, Chieti (S. Iacobelli, L. Irtelli, M.T. Martino); Arcispedale S. Anna, Ferrara (M. Indelli, C. Modenesi); Università degli Studi e Policlinico Careggi, Firenze (V. Distante, R. Simoncini); Ospedale L. Pierantoni, Forlì (D. Amad

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1060, doi. 10.1002/cncr.22513

By:

Francesco Boccardo;
Alessandra Rubagotti;
Daniela Aldrighetti;
Franco Buzzi;
Giorgio Cruciani;
Antonio Farris;
Giorgio Mustacchi;
Mauro Porpiglia;
Giorgio Schieppati;
Piero Sismondi

Publication type:

Article

Author reply.

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1212

By:

Alvaro Moreno‐Aspitia;
Gerardo Colon‐Otero

Publication type:

Article

Cost‐effectiveness analysis of oxaliplatin compared with 5‐fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the USThis study was carried out by i3 Innovus under a grant from Sanofi‐Aventis. Sanofi‐Aventis provided the raw MOSAIC dataset and reviewed article drafts; i3 Innovus carried out all analyses and interpreted data and results independently.

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1082

By:

Samuel Aballéa;
Jeremy V.M. Chancellor;
Maria Raikou;
Michael F. Drummond;
Milton C. Weinstein;
Sophia Jourdan;
John Bridgewater

Publication type:

Article

Thalidomide therapy in adult patients with myelodysplastic syndrome: A North Central Cancer Treatment Group phase II trial.

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1211, doi. 10.1002/cncr.22516

By:

Pellegrino Musto

Publication type:

Article

Improvement of overall survival of patients with cutaneous melanoma in Germany, 1976–2001: Which factors contributed?

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1174

By:

Konstantinos G. Lasithiotakis;
Ulrike Leiter;
Thomas Eigentler;
Helmut Breuninger;
Gisela Metzler;
Friedegund Meier;
Claus Garbe

Publication type:

Article

Overexpression of CXCR4 predicts adverse overall and event‐free survival in patients with unmutated FLT3 acute myeloid leukemia with normal karyotype.

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1152, doi. 10.1002/cncr.22510

By:

Sergej Konoplev;
Georgios Z. Rassidakis;
Elihu Estey;
Hagop Kantarjian;
Chrysoula I. Liakou;
Xuelin Huang;
Lianchun Xiao;
Michael Andreeff;
Marina Konopleva;
L. Jeffrey Medeiros

Publication type:

Article

Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome: Comparison with historical experience.

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1133, doi. 10.1002/cncr.22508

By:

Hagop M. Kantarjian;
Susan O'Brien;
Xuelin Huang;
Guillermo Garcia‐Manero;
Farhad Ravandi;
Jorge Cortes;
Jianqin Shan;
Jan Davisson;
Carlos E. Bueso‐Ramos;
Jean‐Pierre Issa

Publication type:

Article

What is the role of adjuvant radiotherapy in the treatment of cutaneous squamous cell carcinoma with perineural invasion?

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1053, doi. 10.1002/cncr.22509

By:

Anne Han;
Désireé Ratner

Publication type:

Article

Comparison of peripheral T‐cell lymphomas and diffuse large B‐cell lymphoma.

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1146, doi. 10.1002/cncr.22507

By:

Naoto Tomita;
Shigeki Motomura;
Rie Hyo;
Hirotaka Takasaki;
Sachiya Takemura;
Jun Taguchi;
Shin Fujisawa;
Koji Ogawa;
Yoshiaki Ishigatsubo;
Kengo Takeuchi

Publication type:

Article

Impact of a 21‐gene RT‐PCR assay on treatment decisions in early‐stage breast cancer: An economic analysis based on prognostic and predictive validation studiesPresented, in part, at the 42nd Annual Meeting of the American Society of Clinical Oncology, June 2–5, 2006, Atlanta, GA.

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1011, doi. 10.1002/cncr.22506

By:

Gary H. Lyman;
Leon E. Cosler;
Nicole M. Kuderer;
John Hornberger

Publication type:

Article

Noninvasive imaging for evaluation of the systemic delivery of capsid‐modified adenovirus in an orthotopic model of advanced lung cancer.

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1213, doi. 10.1002/cncr.22494

By:

Robert M. Hoffman

Publication type:

Article

Irradiation‐induced telomerase activity and the risk of lung cancer: A pilot case‐control study.

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1157, doi. 10.1002/cncr.22493

By:

Meng Chen;
Jian Gu;
Jinliang Xing;
Margaret R. Spitz;
Xifeng Wu

Publication type:

Article

Tyrosine kinase receptor RON in human pancreatic cancer: Expression, function, and validation as a target.

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1030, doi. 10.1002/cncr.22490

By:

E. Ramsay Camp;
Anthony Yang;
Mike J. Gray;
Fan Fan;
Stanley R. Hamilton;
Douglas B. Evans;
Andrea T. Hooper;
Daniel S. Pereira;
Daniel J. Hicklin;
Lee M. Ellis

Publication type:

Article

Informing prospective research subjects of the influence of regulatory requirements for drug approval on the design of clinical trials in oncology.

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1003, doi. 10.1002/cncr.22491

By:

Maurie Markman

Publication type:

Article

The risk of renal impairment in hormone‐refractory prostate cancer patients with bone metastases treated with zoledronic acidSponsored by F. Hoffmann‐La Roche, Ltd., Basel, Switzerland.

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1090, doi. 10.1002/cncr.22504

By:

William K. Oh;
Kevin Proctor;
Mari Nakabayashi;
Carolyn Evan;
Lauren K. Tormey;
Timothy Daskivich;
Lucia Antràs;
Michael Smith;
Maureen P. Neary;
Mei Sheng Duh

Publication type:

Article

Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon‐alphaAll patients in the study gave written informed consent.

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1097

By:

Kesavan Esuvaranathan;
Edmund Chiong;
Thomas Paulraj Thamboo;
Yiong Huak Chan;
Revathi Kamaraj;
Ratha Mahendran;
Ming Teh

Publication type:

Article

Therapy for elderly patients with acute myeloid leukemiaSee referenced Original Article on pages 000‐000, this issue.: A problem in search of solutions.

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1007, doi. 10.1002/cncr.22502

By:

Hagop M. Kantarjian

Publication type:

Article

A prospective study of tobacco and alcohol use as risk factors for pharyngeal carcinomas in Singapore Chinese.

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1183, doi. 10.1002/cncr.22501

By:

Jeppe T. Friborg;
Jian‐Min Yuan;
Renwei Wang;
Woon‐Puay Koh;
Hin‐Peng Lee;
Mimi C. Yu

Publication type:

Article

Kaposi sarcoma of the musculoskeletal system: A review of 66 patients.

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1040, doi. 10.1002/cncr.22500

By:

Gabriel Caponetti;
Bruce J. Dezube;
Carlos S. Restrepo;
Liron Pantanowitz

Publication type:

Article

Fractionated stereotactic radiotherapy for acoustic neuromaPresented at the 1st Canadian Radiosurgery Society Meeting, Banff, Alberta March 4–5, 2005 (oral); the 19th Annual Meeting of Canadian Association of Radiation Oncology, Victoria, British Columbia, Sept 7–10, 2005, and European Cancer Conference (ECCO 13), Paris, France, Oct 30–Nov 3, 2005 (posters).: Single‐institution experience at the princess margaret hospital

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1203, doi. 10.1002/cncr.22499

By:

Eng‐Siew Koh;
Barbara‐Ann Millar;
Cynthia Ménard;
Howard Michaels;
Mostafa Heydarian;
Shenaz Ladak;
Sharon McKinnon;
John A. Rutka;
Abhijit Guha;
Gregory R. Pond;
Normand J. Laperriere

Publication type:

Article

Treatment of chronic myeloid leukemia in the imatinib era: Perspective from a developing country.

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1138, doi. 10.1002/cncr.22498

By:

Zeba Aziz;
Javaid Iqbal;
Mohammad Akram;
Sarah Saeed

Publication type:

Article

A Decision analysis to determine the appropriate treatment for low‐risk myelodysplastic syndromesPresented in part at the 47th annual meeting of the American Society of Hematology, December 11, 2005, and published in abstract form.

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1125, doi. 10.1002/cncr.22497

By:

Mikkael A. Sekeres;
Alex Z. Fu;
Jaroslaw P. Maciejewski;
Ali‐Reza Golshayan;
Matt E. Kalaycio;
Michael W. Kattan

Publication type:

Article

Author reply.

Published in:

Cancer (0008543X), 2007, v. 109, n. 6, p. 1214, doi. 10.1002/cncr.22459

By:

Akseli Hemminki;
Merja Särkioja;
Jarmo Salo

Publication type:

Article